Skip to search formSkip to main contentSkip to account menu

bopindolol

Known as: 1-(tert-butylamino)-3-((2-methylindo)-4-yl)-2-propanol benzoate, 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((2-methyl-1H-indol-4-yl)oxy)-, benzoate (ester), (+-)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryTen healthy subjects whose genetic oxidative phenotype had been determined (6 extensive and 4 poor metabolizers of the… 
Highly Cited
1999
Highly Cited
1999
The mechanisms for the vascular actions of vasodilatory beta-blockers remain undetermined. For some kinds of beta-blockers, the… 
Review
1989
Review
1989
  • W. Roberts
  • American heart journal
  • 1989
  • Corpus ID: 26839052
Review
1989
Review
1989
  • M. Lennard
  • Pharmacology & therapeutics
  • 1989
  • Corpus ID: 46453944
1988
1988
We have previously reported that a potent new beta-blocker, tertatolol, when given at therapeutic doses to healthy volunteers… 
1986
1986
Bopindolol, an esterified beta-adrenoceptor blocking drug, was administered to nine healthy male volunteers in oral (1 mg and 4… 
1985
1985
  • W. H. Aellig
  • British journal of clinical pharmacology
  • 1985
  • Corpus ID: 178184
Bopindolol is a potent and specific beta-adrenoceptor antagonist with partial agonist activity. In animal experiments it blocks… 
1984
1984
Bopindolol has β‐blocking effects for 96 hr despite a 4‐hr t½. To investigate the concentration‐effect relationship after single…